FDA moves to minimize risks tied to mad cow disease.(Across Specialties)(Food and Drug Administration) : An article from: Clinical Psychiatry News [HTML]

Book Description
This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on April 1, 2004. The length of the article is 689 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation Details
Title: FDA moves to minimize risks tied to mad cow disease.(Across Specialties)(Food and Drug Administration)
Author: Heidi Splete
Publication: Clinical Psychiatry News (Magazine/Journal)
Date: April 1, 2004
Publisher: International Medical News Group
Volume: 32 Issue: 4 Page: 103(1)Distributed by Thompson Gale

Excerpt. © Reprinted by permission. All rights reserved.

SILVER SPRING, MD. -- Tracking infected cows, banning the use of cattle feed made from cow parts, and testing cows are three of the actions that the Food and Drug Administration has taken in response to the discovery of a case of bovine spongiform encephalopathy, known as "mad cow disease," in a cow that entered the United States from Canada.